Davies M. A., Saiag P., Robert C., Grob J. J., Flaherty K. T., Arance A., Chiarion-Sileni V., Thomas L., Lesimple T., Mortier L., Moschos S. J., Hogg D., Márquez-Rodas I., Del Vecchio M., Lebbé C., Meyer N., Zhang Y., Huang Y., Mookerjee B., Long G. V.
Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Lancet Oncol..
2017
;18
:863-873
Kluger N., Lebbe C., Grange F., Mortier L., Robert C.
Dermatological oncology: advanced melanoma, side effects of anti-PD1, place of monotherapy in the first line, treatment of metastatic melanoma.
Ann. Dermatol. Venereol..
2017
;144
:S11-S14
Frouin F., Melodelima D., de la Chapelle M. L., Vermandel M.
Reporting New Methods and New Results in Biomedical Engineering: Why Not Choosing IRBM?.
IRBM.
2017
;38
:1-2